Sign up to save your podcasts
Or
Share Post-Vaccine Stock Picks — Is YOUR portfolio ready?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Post-Vaccine Stock Picks — Is YOUR portfolio ready?
The stock market doesn’t need a vaccine. It just needs positive news about the possibility of a vaccine. That’s what saw Monday. The positive interim phase 1 trial press release from biotech Moderna was a great trial run for investors. Today on Dumb Money Live, what news are we looking for? What stocks will benefit most? And more importantly, how are we are tming our entry points on the next news of a vaccine?
View all episodes
By Dumb Money
4.7
9494 ratings
The stock market doesn’t need a vaccine. It just needs positive news about the possibility of a vaccine. That’s what saw Monday. The positive interim phase 1 trial press release from biotech Moderna was a great trial run for investors. Today on Dumb Money Live, what news are we looking for? What stocks will benefit most? And more importantly, how are we are tming our entry points on the next news of a vaccine?
More shows like Dumb Money Live
View all
Motley Fool Money
3,189 Listeners
Top Traders Unplugged
587 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,371 Listeners
Stansberry Investor Hour
680 Listeners
Animal Spirits Podcast
1,996 Listeners
The Pomp Podcast
1,832 Listeners
Chit Chat Stocks
186 Listeners
The Market Huddle
358 Listeners
Investing With IBD
382 Listeners
The Compound and Friends
2,040 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
8,778 Listeners
RiskReversal Pod
786 Listeners
Forward Guidance
273 Listeners
Bloomberg Talks
14 Listeners
BG2Pod with Brad Gerstner and Bill Gurley
432 Listeners